Susquehanna raised the firm’s price target on Teradyne (TER) to $335 from $275 and keeps a Positive rating on the shares. The firm said strong 4Q25 results reinforce their view that the company is undergoing a structural expansion in earnings power driven by multiple AI-related growth vectors.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TER:
- Teradyne price target raised to $305 from $195 at Baird
- Teradyne price target raised to $325 from $215 at Citi
- Teradyne price target raised to $300 from $230 at Goldman Sachs
- Teradyne: AI-Driven Test Demand and Expanding ATE Market Support Multi-Year Growth and Buy Rating
- Teradyne price target raised to $288 from $229 at Morgan Stanley